$WMT

Walmart Stock Falls 9% After Q2 Profit Declines

Walmart (WMT) shares dropped 9.06% to $103.95 after reporting lower Q2 profit ($6.366B) despite higher revenue ($187.937B). The company expects Q3 earnings of $0.62-$0.64 per share and full-year earnings of $2.80-$2.87 per share.

Original reporting
Published Aug 20, 2026, 4:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 4:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Walmart Stock Falls 9% After Q2 Profit Declines — source image
Decision brief

The 30-second read

$WMTBearishHigh
01

Why it matters

The earnings miss and lowered guidance suggest near‑term weakness for the stock and may influence retail sector sentiment.

02

Market read

Walmart's earnings miss is a material event for the consumer‑discretionary sector and may drive broader market caution.

03

What to watch

Potential cost‑saving initiatives and upcoming holiday season sales could mitigate the earnings shortfall.

Relevance 9/10Novelty 9/10Timing: post‑market today

Background

Walmart's Q2 results showed revenue growth but a notable decline in profit and earnings per share, leading to a 9% drop in the share price.

Company-level read

Ticker impact

$WMTBearishHigh confidence
Context

Walmart reported Q2 net income fell to $6.366B and earnings per share dropped to $0.80, causing the stock to fall 9% intraday.

Expected impact

Further downside pressure if guidance remains below expectations; potential short‑term rebound if management provides clarifying commentary.

Evidence & confidence

The combination of a 9% price drop, earnings miss, and reduced Q3 guidance signals immediate market reaction and heightened volatility.

Market effects

Retail sector may face pressure as Walmart's slowdown hints at broader consumer spending concerns.

U.S. consumer‑discretionary stocks could see heightened volatility.

International retailers may be impacted by Walmart's earnings trend as a bellwether.

Counterpoint

If Walmart can improve margin performance, the stock may be oversold after the sharp decline.

Key entities

  • Walmart Inc.

    U.S. retail giant reporting Q2 earnings.

Related articles

$WMTMedAI 8/10

Walmart Sees Grocery Growth as Shoppers Prioritize Affordability

Walmart reported Q2 2027 sales growth of 2.6% in the U.S., missing estimates and causing shares to drop 8%. CEO John Furner attributed slower growth to higher gasoline prices and consumers seeking value. Grocery sales rose by a mid-single-digit percentage, with strong unit volumes. The company increased price rollbacks to over 11,000 and saw growth in eCommerce and membership services. Walmart raised its full-year sales growth forecast to 4-5%.

$WMTHighAI 9/10

Walmart Reports Strong Q2 Online Sales, But Store Results Disappoint Analysts

Walmart reported Q2 2027 revenue up 5.9%, operating income up 28.8%, and net income of $6.4B, driven by 23% online sales growth and a $2.9B tariff refund. Despite raising its annual forecast, shares fell 9.32% due to weaker in-store sales growth of 2.6%. Analysts note Walmart's value appeal across income levels and its focus on private labels and AI.

$WMTHighAI 8/10

Walmart Crashes Most Since 2022 After Huge Comp Store Sales Miss

Walmart's shares fell 9% after Q2 results missed expectations, with US comp sales ex-gas at +2.6% vs. estimates of +3.67%. Adjusted EPS beat at $0.81, while revenue rose 5.9% YoY to $187.94B. Guidance for Q3 and FY2027 missed consensus. The company cited pharmacy deflation and drug price regulations as headwinds. Operating cash flow was $19.7B, with $3B spent on share repurchases.

$WMTHighAI 9/10

Walmart Stock Falls After Q2 Earnings Flash Warning for US Economy

Walmart reported Q2 earnings that beat estimates but showed slowing US sales growth and consumer spending. Comparable sales grew 2.6% (excluding fuel), missing expectations. Shares fell 9%. The company cited price pressures and federal drug price negotiations as challenges. Analysts note consumer spending may be slowing, impacting the broader economy.